kisspeptin receptor antagonists (Crinetics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namekisspeptin receptor antagonists (Crinetics)
Drug Alias Namenonpeptide KISS1R antagonists (Crinetics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKisspeptins receptor inhibitors
TargetsKisspeptins receptor
Therapy Area/IndicationsUterine FibroidsEndometriosisPolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrinetics Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUterine FibroidsEndometriosisPolycystic Ovary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A